ACADIA HEALTHCARE COMPANY INC

NASDAQ: ACHC (Acadia Healthcare Company, Inc.)

Last update: 13 Oct, 10:43PM

24.29

0.03 (0.12%)

Previous Close 24.26
Open 24.67
Volume 1,348,254
Avg. Volume (3M) 2,738,029
Market Cap 2,243,098,880
Price / Earnings (TTM) 15.98
Price / Earnings (Forward) 10.15
Price / Sales 0.760
Price / Book 0.800
52 Weeks Range
17.13 (-29%) — 60.52 (149%)
Earnings Date 30 Oct 2025
Profit Margin 5.94%
Operating Margin (TTM) 10.19%
Diluted EPS (TTM) 2.04
Quarterly Revenue Growth (YOY) 0.30%
Quarterly Earnings Growth (YOY) -89.00%
Total Debt/Equity (MRQ) 74.09%
Current Ratio (MRQ) 1.35
Operating Cash Flow (TTM) 462.46 M
Levered Free Cash Flow (TTM) -276.20 M
Return on Assets (TTM) 5.06%
Return on Equity (TTM) 6.33%

Market Trend

Short Term Medium Term
Industry Medical Care Facilities (US) Bullish Mixed
Medical Care Facilities (Global) Bullish Mixed
Stock Acadia Healthcare Company, Inc. Mixed Bearish

AIStockmoo Score

-0.8
Analyst Consensus 1.5
Insider Activity 1.5
Price Volatility -2.0
Technical Moving Averages -2.5
Technical Oscillators -2.5
Average -0.80

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ACHC 2 B - 15.98 0.800
HCSG 1 B - 34.24 2.51
INNV 625 M - - 2.87
CCRN 430 M - - 1.04
TOI 417 M - - 0.760
AIRS 321 M - - 5.45

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

Sector Healthcare
Industry Medical Care Facilities
Investment Style Small Value
% Held by Insiders 1.75%
% Held by Institutions 109.93%

Ownership

Name Date Shares Held
Abrams Bison Investments, Llc 30 Jun 2025 3,580,000
52 Weeks Range
17.13 (-29%) — 60.52 (149%)
Price Target Range
17.00 (-30%) — 35.00 (44%)
High 35.00 (Keybanc, 44.09%) Buy
Median 28.00 (15.27%)
Low 17.00 (Barclays, -30.01%) Hold
Average 26.56 (9.35%)
Total 5 Buy, 4 Hold
Avg. Price @ Call 21.44
Firm Date Target Price Call Price @ Call
Cantor Fitzgerald 07 Nov 2025 22.00 (-9.43%) Hold 20.68
07 Oct 2025 25.00 (2.92%) Hold 27.23
Barclays 06 Nov 2025 17.00 (-30.01%) Hold 20.68
07 Aug 2025 20.00 (-17.66%) Hold 18.20
Keybanc 08 Oct 2025 35.00 (44.09%) Buy 25.60
Raymond James 03 Oct 2025 30.00 (23.51%) Buy 27.14
14 Aug 2025 26.00 (7.04%) Buy 20.66
B of A Securities 10 Sep 2025 25.00 (2.92%) Hold 21.06
Mizuho 14 Aug 2025 22.00 (-9.43%) Hold 20.66
RBC Capital 13 Aug 2025 28.00 (15.27%) Buy 20.77
Guggenheim 07 Aug 2025 29.00 (19.39%) Buy 18.20
UBS 07 Aug 2025 31.00 (27.62%) Buy 18.20
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
YOUNG TODD S. 22.95 - 48,445 1,111,813
Aggregate Net Quantity 48,445
Aggregate Net Value ($) 1,111,813
Aggregate Avg. Buy ($) 22.95
Aggregate Avg. Sell ($) -
Name Holder Date Type Quantity Price Value ($)
YOUNG TODD S. Officer 27 Oct 2025 Acquired (+) 48,445 22.95 1,111,813

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria